Hinge Health, Inc. (HNGE)
99.16
-5.80
(-5.53%)
USD |
NYSE |
Oct 16, 16:00
98.50
-0.66
(-0.67%)
Pre-Market: 20:00
Hinge Health Research and Development Expense (Annual) : 368.14M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 368.14M |
| December 31, 2024 | 97.49M |
| Date | Value |
|---|---|
| December 31, 2023 | 110.06M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| West Pharmaceutical Services, Inc. | 74.30M |
| Vivos Therapeutics, Inc. | 0.10M |
| Exlites Holdings International, Inc. | -- |
| Xcelerate, Inc. | -- |
| Teleflex, Inc. | 144.78M |